Wired News – Teleflex Signs Group Purchasing Agreement with HealthTrust for Respiratory Heaters & Accessories
Stock Monitor: The Cooper Cos. Post Earnings Reporting
LONDON, UK / ACCESSWIRE / December 14, 2017 / Active-Investors issued a free report on Teleflex Inc. (NYSE: TFX), which is readily accessible upon registration at www.active-investors.com/registration-sg/?symbol=TFX as the Company's latest news hit the wire. On December 12, 2017, the Company declared that its respiratory division has signed a new group purchase agreement with HealthTrust, a healthcare group purchasing organization, for respiratory heaters and accessories. The agreement covers Teleflex's full line of Active Humidification, Non Invasive Ventilation (NIV), and High Flow Nasal Cannula Therapy (HFNCT) products. Sign up now for our free research reports at:
www.active-investors.com/registration-sg
Active-Investors.com is currently working on the research report for The Cooper Companies, Inc. (NYSE: COO), which also belongs to the Healthcare sector as the Company Teleflex. Do not miss out and become a member today for free to access this upcoming report at:
www.active-investors.com/registration-sg/?symbol=COO
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Teleflex most recent news is on our radar and we have decided to include it on our blog post. Today's free coverage is available at:
www.active-investors.com/registration-sg/?symbol=TFX
Agreement Provides HealthTrust Access to Teleflex's Wide Range of Humidification Products
The agreement provides HealthTrust's more than 400 member hospitals with access to Teleflex's wide range of humidification products, including the Hudson RCI® Neptune® Heated Humidifier with ConchaSmartTM Technology and ISO-Gard® Heated Wire Circuit Technology, and Comfort Flo® Plus High Flow Nasal Cannula. This contract complements the existing General Respiratory Agreement, providing HPG members an opportunity to consolidate their respiratory purchases with one supplier.
Teleflex is Well Positioned to Offer a Full Suite of Respiratory Solutions
Commenting on the agreement, James Ferguson, President Respiratory and Latin America, Teleflex, stated that the Company is well positioned to offer a full suite of respiratory solutions to the clinical community, demonstrating its commitment to expand access to technology that helps clinicians improve outcomes while reducing overall healthcare costs.
Teleflex's History of Purchasing Agreements with HealthTrust
Agreements in 2016 - In January 2016, the Company signed a purchase agreement with HealthTrust, covering its full line of manual ligation products, including the Weck® Hem-o-Lok® polymer locking system, Horizon™ Titanium Clip System, Hemoclip® Metal Clips, and associated appliers. On April 28, 2016, Teleflex's Anesthesia Division signed two new group purchasing agreements with HealthTrust, one for laryngeal mask airways, and the other for pain management solutions.
Agreements in 2015 - On January 13, 2015, the Company struck an agreement with HealthTrust covering its peripherally inserted central catheter (PICC) and tip location devices. Teleflex signed two agreements covering its Central Venous Catheter (CVC) and Weck EFx® Portfolio of Port Closure products, in April and July, respectively.
Agreements in 2013 - Teleflex was awarded an agreement for its line of ligation products with HealthTrust in January 2013. In the same year, Teleflex entered into two more purchasing agreements with HealthTrust, for its line of regional anesthesia products, and complete line of LMA® Laryngeal Masks.
Teleflex's Purchasing Contract with Vizient
On August 23, 2017, Teleflex announced a new three year Product Category contract with Vizient Inc. for non-tunneled central venous catheters. Vizient is the largest member-driven health care performance improvement Company in the country. The agreement provided Vizient's members increased savings on contracts that offer Teleflex's wide range of catheter kits, which are designed to protect patients against unnecessary catheter related complications.
About Teleflex Inc.
Founded in 1981 and headquartered in Wayne, Pennsylvania, Teleflex is a global provider of medical technologies that enhance clinical benefits, improve patient and provider safety, and reduce total procedural costs. The Company's portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care.
About HealthTrust
HealthTrust provides performance and clinical excellence through an aligned membership model and the delivery of total spend management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope, and value. Headquartered in Nashville, Tennessee, the Company serves approximately 1,600 acute care facilities and members in more than 26,000 other locations.
Stock Performance Snapshot
December 13, 2017 - At Wednesday's closing bell, Teleflex's stock marginally rose 0.82%, ending the trading session at $251.91.
Volume traded for the day: 365.58 thousand shares, which was above the 3-month average volume of 257.57 thousand shares.
Stock performance in the last three-month – up 7.52%; previous six-month period – up 26.04%; past twelve-month period – up 61.15%; and year-to-date - up 56.32%
After yesterday's close, Teleflex's market cap was at $11.34 billion.
Price to Earnings (P/E) ratio was at 45.50.
The stock has a dividend yield of 0.54%.
The stock is part of the Healthcare sector, categorized under the Medical Instruments & Supplies industry. This sector was up 0.3% at the end of the session.
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
